abs165.txt	purpose		retrospective	analyses	of	cancer	registry	and	institutional	data	haveconsistently	found	better	survival	after	radical	prostatectomy	versus	radiationtherapy	which	contrasts	with	findings	from	a	randomized	trial	this	is	likelybecause	the	inability	studies	to	fully	account	forcomorbidity	differences	across	treatment	groups	because	lack	detaileddata	in	registries	we	use	unique	population-based	set	regarding	comorbidities	functional	limitations	assess	whether	thiscan	provide	valid	comparisons	prostate	treatmentgroups	methods	materials	surveillance	epidemiology	end	results(seer)-medicare	health	outcomes	survey	(mhos)	results	linkagebetween	seer	database	mhos	includes	detailedinformation	patient-reported	comorbidity	weanalyzed	3102	patients	seer-mhos	used	latent	classanalysis	identify	healthiest	group	minimal	burden	andfunctional	among	examined	overall	survivalacross	treatments	using	kaplan-meier	method	three	distinct	were	identified	comprised	57%	cohort	had	10-yearoverall	67%	other	higher	rates	orfunctional	10-year	survivaldiffered	no	local	(55%)	external	beamradiation	therapy	(69%)	brachytherapy	(76%)	(85%)	curves	for	3	treated	separated	at	4	years	follow-up	conclusions	despite	detailed	status	information	available	inseer-mhos	our	analysis	could	not	patientselection	biases	these	findingshighlight	an	important	limitation	population-baseddata	sets	serve	as	reminder	interpret	caution
